Post-IPO Equity - Diamyd Medical
Investment Firm
Overview
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.
Announced Date
Apr 18, 2024
Funding Type
Post Ipo Equity
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Diamyd Medical raised $5192567 on 2024-04-18 in Post-IPO Equity
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 21, 2006 |  Pre Seed Round - Diamyd Medical | 1 | - | 100.0K |
| Apr 04, 2023 | Grant - Diamyd Medical | 1 | - | 5.0M |
| Apr 16, 2024 | Post-IPO Equity - Diamyd Medical | 2 | - | 5.2M |
| Apr 18, 2024 | Post-IPO Equity - Diamyd Medical | 2 | - | 5.2M |
Recent Activity
News
Apr 18, 2024
News Powered by Cision - Diamyd Medical announces final outcome in the company’s rights issue
News
Apr 18, 2024
diamyd.com - Diamyd Medical announces final outcome in the company’s rights issue
News
Apr 16, 2024
diamyd.com - Diamyd Medical announces preliminary outcome in the company’s rights issue